×
Site Menu
Everything
International
Politics
Local
Finance
Sports
Entertainment
Lifestyle
Technology
Literature
Science
Health
Atea Pharmaceuticals GAAP EPS of -$0.44 beats by $0.01
2 hours ago
2
Earnings News
Comments
Atea Pharmaceuticals
press release
(
NASDAQ:
AVIR
): Q2 GAAP EPS of -$0.44
beats by $0.01
.
Cash, Cash Equivalents and Marketable Securities: $379.7 million at June 30, 2025 compared to $454.7 million at December 31, 2024.
More on Atea Pharmaceuticals
Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
Historical earnings data for Atea Pharmaceuticals
Financial information for Atea Pharmaceuticals
Recommended For You
More
Trending News
See More »
Read Entire Article
Homepage
Politics
Atea Pharmaceuticals GAAP EPS of -$0.44 beats by $0.01
Related
Occidental's direct air capture hub to step start operations...
36 minutes ago
1
BHP, Vale offered $1.4B to settle Brazil mining dam lawsuit ...
1 hour ago
1
Vroom GAAP EPS of -$1.65, revenue of $41.42M
1 hour ago
1
5 Netflix Shows That Are Perfect For Fans Of ‘The Hunting Wi...
1 hour ago
1
Concentra Group Holdings Parent declares $0.0625 dividend
1 hour ago
0
GPT-5 Is Launched But Set Aside Your Expectations That This ...
1 hour ago
1
Trending
1.
malaki starks
2.
adonai mitchell
3.
maduro venezuela
4.
mariners game
5.
espn nfl
6.
david ojabo
7.
derrick henry
8.
mariners game today
9.
dream vs sky
10.
keaton mitchell
Popular
Listen to the sounds of a black hole with these NASA sonific...
2 months ago
75
Palm Springs Bombing: What We Know About Fertility Clinic Ex...
2 months ago
66
Oil futures fall as Saudi Arabia said to seek more big OPEC ...
2 months ago
49
This is the next historical period I want to see in Assassin...
2 months ago
44
UK's unemployment rate rises to 4.6% in April
1 month ago
41